SBFM Track Record proves a lot about management and there is only one thing that’s clear to me, they are very consistent.
Financing:
Duchess - Fail
Jitney - Fail
GHS - cancelled, Fail
First Batch manufacturing
Lonza pharma Fail
Garmen Labs - Fail
Crocus pharma - no news
Acquisitions
Garmen Labs - Fail
Atlas labs - No news no revenues, Fail
Clinical Trials
Jewish Hospital - No news, no updates
TBD
You can call it lies, you can call it manipulation or you can call it delays, but it’s very obvious to me, you can’t trust anything they say.